How NVIDIA grew with the healthcare market instead of pushing into it
As the use of AI soared across healthcare, NVIDIA fit the bill in providing the necessary technology – and its stock tells the same story.
Artificial Intelligence
Lilly joins fellow pharma giants in OpenAI partnership
Ability Biologics closes extended $18m seed funding round
Cyrus Biotechnology to spin out Levitate Bio for biopharma AI
Sanofi enters partnership to enhance drug development using AI
UK clinical trials industry tackles recent changes in the sector
